英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
imbecilic查看　imbecilic　在百度字典中的解释百度英翻中〔查看〕
imbecilic查看　imbecilic　在Google字典中的解释Google英翻中〔查看〕
imbecilic查看　imbecilic　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • OPDIVO U. S. Prescribing Information - BMS
    OPDIVO® (nivolumab) injection, for intravenous use Initial U S Approval: 2014-----RECENT MAJOR CHANGES-----Indications and Usage (1) 5 2025 Dosage and Administration (2) 5 2025
  • Food and Drug Administration
    Food and Drug Administration
  • OPDIVO® (nivolumab)
    OPDIVO ® (nivolumab) is a prescription medicine used in combination with YERVOY ® (ipilimumab) and 2 cycles of chemotherapy that contains platinum and another chemotherapy medicine, as a first treatment for adults with a type of advanced stage lung cancer (called non-small cell lung cancer) when your lung cancer has spread or grown, or comes bac
  • OPDIVO- nivolumab injection - DailyMed
    See How Supplied section for a complete list of available packages of OPDIVO NDC 0003-3772-11 - Rx only - Opdivo® (nivolumab) injection - 40 mg 4 mL - (10 mg mL) For intravenous Infusion
  • Opdivo: Package Insert Prescribing Information - Drugs. com
    Opdivo package insert prescribing information for healthcare professionals Includes: indications, dosage, adverse reactions and pharmacology
  • Adverse Reaction Severity Dose Modi˜cation Nivolumab INN
    Nivolumab is a human immunoglobulin G4 (IgG4) monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2, releasing PD-1 pathway-mediated inhibition of the immune response, including the anti-tumor immune response In syngeneic mouse tumor models, blocking PD-1 activity resulted in decreased tumor growth
  • Dosing Information | OPDIVO® (nivolumab)
    Find instructions for preparation, administration, and storage for both OPDIVO infusions and OPDIVO Qvantig subcutaneous injections Go to Info A guide to dosing intravenous OPDIVO and subcutaneous injection OPDIVO Qvantig Download ⤓ OPDIVO Qvantig [package insert] Princeton, NJ: Bristol-Myers Squibb Company OPDIVO [package insert]
  • OPDIVO (nivolumab) injection Label - Food and Drug Administration
    OPDIVO (nivolumab) is indicated for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF
  • OPDIVO QVANTIG U. S. Prescribing Information
    OPDIVO QVANTIG is a combination of nivolumab, a programmed death receptor-1 (PD-1)-blocking antibody, and hyaluronidase, an endoglycosidase, indicated for the treatment of: Renal Cell Carcinoma (RCC) • adult patients with intermediate or poor risk advanced RCC, as a first-line treatment
  • Nivolumab - Amazon Web Services
    Package insert: Nivolumab Intravenous Cancer Treatment Education (Explore the treatment regimens associated with this drug by searching





中文字典-英文字典  2005-2009